Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 18:7:451.
doi: 10.3389/fphys.2016.00451. eCollection 2016.

Cross Talk between the Calcium-Sensing Receptor and the Vitamin D System in Prevention of Cancer

Affiliations
Review

Cross Talk between the Calcium-Sensing Receptor and the Vitamin D System in Prevention of Cancer

Abhishek Aggarwal et al. Front Physiol. .

Abstract

There is epidemiological evidence for the cancer preventive effect of dietary calcium (Ca2+) and vitamin D. This effect is strongest in colorectal cancer (CRC). The active vitamin D metabolite, 1,25-dihydroxyvitamin D3 (1,25D3), bound to its receptor, the vitamin D receptor (VDR) regulates the expression of hundreds of different genes in a cell- and tissue-specific manner. While Ca2+ acts through multiple mechanisms and pathways, some of its effects are mediated by the calcium-sensing receptor (CaSR). The joint action of Ca2+ and 1,25D3 is due to the fact that both regulate some of the main processes involved in the development of various cancers, such as proliferation, differentiation, apoptosis, migration, and inflammation. Moreover, 1,25D3, bound to VDR can induce translation of the CaSR, while the amount and activity of the CaSR affects 1,25D3 signaling. However, the complexity of the cross-talk between the CaSR and the vitamin D system goes beyond regulating similar pathways and affecting each other's expression. Our aim was to review some of the mechanisms that drive the cross-talk between the vitamin D system and the CaSR with a special focus on the interaction in CRC cells. We evaluated the molecular evidence that supports the epidemiological observation that both vitamin D and calcium are needed for protection against malignant transformation of the colon and that their effect is modulated by the presence of a functional CaSR.

Keywords: CaSR; VDR; VDRE; calcium; colorectal cancer; vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Impact of the inactivating CaSR mutation on the apoptotic effect of 1,25D3 and NPS R-568 in the colon cancer cell lines Caco2-15 (A) and HT29 (B), stably transfected with wild type (CaSR-WT) or the dominant negative R185Q mutant (CaSR-DN). Cells transfected with and empty vector (EMP) were used as controls. One week post confluence, the cells were treated with 1,25D3 (1 nM), NPS R-568 (1 μM) or a combination of 1,25D3 and NPS R-568 for 48 h. Apoptosis was assessed by measuring caspase3/7 activity. Bars represent mean ± SEM. Statistical significance was calculated using two-way ANOVA followed by Tukey's correction. *p < 0.05, **p < 0.01, ***p < 0.001. Modified from Aggarwal et al. (2016).
Figure 2
Figure 2
Interactions between the vitamin D system and the CaSR. Ca/CaSR and the 1,25D3/VDR cross talk to protect colonic epithelial cells from malignant transformation. 1,25D3 is able to up regulate expression of both, CaSR and Cyp24a1. The wild type CaSR has a tumor suppressive role in the colon promoting (blue arrows) differentiation and apoptosis and suppressing (red arrows) proliferation and EMT and potentiates the tumor preventive effects of 1,25D3. The presence of a DN mutant CaSR abrogates the tumor preventive effects of both Ca and 1,25D3.

References

    1. Aggarwal A., Hobaus J., Tennakoon S., Prinz-Wohlgenannt M., Graca J., Price S. A., et al. (2016). Active vitamin D potentiates the anti-neoplastic effects of calcium in the colon: A cross talk through the calcium-sensing receptor. J. Steroid Biochem. Mol. Biol. 155(Pt B), 231–238. 10.1016/j.jsbmb.2015.02.006 - DOI - PubMed
    1. Aggarwal A., Prinz-Wohlgenannt M., Groschel C., Tennakoon S., Meshcheryakova A., Chang W., et al. (2015a). The calcium-sensing receptor suppresses epithelial-to-mesenchymal transition and stem cell-like phenotype in the colon. Mol. Cancer 14, 61. 10.1186/s12943-015-0330-4 - DOI - PMC - PubMed
    1. Aggarwal A., Prinz-Wohlgenannt M., Tennakoon S., Hobaus J., Boudot C., Mentaverri R., et al. (2015b). The calcium-sensing receptor: a promising target for prevention of colorectal cancer. Biochim. Biophys. Acta. 1853, 2158–2167. 10.1016/j.bbamcr.2015.02.011 - DOI - PMC - PubMed
    1. Ahearn T. U., Tchrakian N., Wilson K. M., Lis R., Nuttall E., Sesso H. D., et al. (2016). Calcium-sensing receptor tumor expression and lethal prostate cancer progression. J. Clin. Endocrinol. Metab. 101, 2520–2527. 10.1210/jc.2016-1082 - DOI - PMC - PubMed
    1. Ahn J., Park S., Zuniga B., Bera A., Song C. S., Chatterjee B. (2016). Vitamin D in prostate cancer. Vitam. Horm. 100, 321–355. 10.1016/bs.vh.2015.10.012 - DOI - PubMed

LinkOut - more resources